A randomized, 6-week, double-blind, parallel study to evaluate the efficacy and the safety of flexible doses of extended release OROS paliperidone compared with olanzapine in the treatment of patients with schizophrenia.

Trial Profile

A randomized, 6-week, double-blind, parallel study to evaluate the efficacy and the safety of flexible doses of extended release OROS paliperidone compared with olanzapine in the treatment of patients with schizophrenia.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Paliperidone (Primary) ; Olanzapine
  • Indications Schizophrenia
  • Focus Registrational; Therapeutic Use
  • Sponsors Xian-Janssen
  • Most Recent Events

    • 04 May 2010 Actual patient number (288) added as reported by ClinicalTrials.gov.
    • 19 Oct 2007 Status changed from in progress to completed.
    • 26 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top